Hint mode is switched on Switch off

Avidity Biosciences, ordinary share
RNA, US05370A1088

Add a stock to WL
Choose all Reset all
Avidity Biosciences, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Avidity Biosciences Inc operates as a biotechnology company and serves customers in the United States.
  • Issuer
  • Full borrower / issuer name
    Avidity Biosciences Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RNA
  • Placement
    28.06.2013
  • Lock up period
    180
  • Number of papers
    6,000,000
  • Volume of raised funds
    78 mln USD
  • Final placement price
    13 USD
  • Price change since placement date
    -11.15%
  • By capitalization
    455.03 mln USD
Other placements of the issuer
  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    RNA
  • Placement
    12.06.2020
  • Lock up period
    180
  • Number of papers
    14,400,000
  • Volume of raised funds
    259.2 mln USD
  • Placement share
    17.14%
  • Final placement price
    18 USD
  • Price change since placement date
    -35.83%
  • By capitalization
    636.31 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
II q eng
III q eng
IV q eng
Show all Hide

Indicators

News

26/02/2026 Avidity Biosciences: Termination Of A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change Of Fiscal Year, Financial Statements And Exhibits
26/02/2026 Avidity Biosciences: Submission Of Matters To A Vote Of Security Holders
14/12/2025 Avidity Biosciences: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
10/11/2025 Avidity Biosciences: Of This Current Report Onform8k,including Exhibit99.1, Shall Not Be Deemed “filed” For Purposes Of Section18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Incorporated By Reference In Any Filing Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Whether Made Before Or After The Date Hereof, Except As Expressly Set Forth By Specific Reference In Such Filing, Financial Statements And Exhibits
27/10/2025 Avidity Biosciences Acquisition by Novartis Highlights Big Pharma's Interest in RNA Therapies
All organization news

Holders

Industry Leaders

Registration is required to get access.